Archive - February 2021
Oxford University to develop Alzheimer’s disease treatments with Exscientia
GSK, Vir look beyond COVID-19 to develop new therapies for flu and other respiratory viruses
A New Potential Danger from your iPhone?
Best CBD Gummies For 2021
Lilly signs $960m deal with Rigel to develop RIPK1 inhibitors
AZ/Merck & Co’s PARP inhibitor Lynparza scores trial win in early breast cancer
Pfizer/BioNTech and Moderna increase COVID-19 vaccine supplies to the EU
The print edition of T40 2020 is available now!